CAS
2009273-67-8
Formulation
A solid
Purity
≥98%
MW
330,38328
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An inhibitor of USP7 (IC50 = 0.75 µM); selective for USP7 over USP47 and USP5 (IC50s = 20.3 and >200 µM, respectively); enhances ubiquitination of the USP7 substrate MDM2 in HCT116 colon cancer cells (IC50 = 0.23 µM); reduces cell viability in a panel of 108 cell lines (IC50s = <10 µM for all); enhances apoptosis induced by doxorubicin or cisplatin in MCF-7 and U2OS cancer cells, respectively
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).